Zymeworks's chart data is dated 2026-10-08. There is no active technical signal. There are 3 published signal records.
Zymeworks last closed at $25.26 (-4.79%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -12.3×. Its overall grade ranks 601 of 738 stocks in Healthcare.
About this company
Zymeworks last closed at $25.26 (-4.79%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 601/738
Valuation grade B
Related stocks
- Bristol Myers SquibbCustomer
Zymeworks의 파트너십 및 항암제 공동개발 관련 주요 고객/협력사
- Jazz PharmaceuticalsCustomer
Zymeworks 항체·이중항체 파이프라인의 상업화/라이선스 협력 대상
- Merck & Co.Competitor
면역항암·종양학 신약 시장에서 Zymeworks의 경쟁 대상
About Zymeworks
- What technical signals does Zymeworks (ZYME) have?
- Zymeworks current technical signals: no active technical signal.
- Is Zymeworks a cup-and-handle pattern?
- No. Zymeworks has no valid Cup signal right now.
- What published figures are available for Zymeworks?
- Market cap: $1.9B. Trailing 12 months PER: -12.3×. Latest quarter PBR: 22.94×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Zymeworks, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.